Cargando…
Schistosoma haematobium Extracellular Vesicle Proteins Confer Protection in a Heterologous Model of Schistosomiasis
Helminth parasites release extracellular vesicles which interact with the surrounding host tissues, mediating host–parasite communication and other fundamental processes of parasitism. As such, vesicle proteins present attractive targets for the development of novel intervention strategies to contro...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563238/ https://www.ncbi.nlm.nih.gov/pubmed/32722279 http://dx.doi.org/10.3390/vaccines8030416 |
_version_ | 1783595445653602304 |
---|---|
author | Mekonnen, Gebeyaw G. Tedla, Bemnet A. Pickering, Darren Becker, Luke Wang, Lei Zhan, Bin Bottazzi, Maria Elena Loukas, Alex Sotillo, Javier Pearson, Mark S. |
author_facet | Mekonnen, Gebeyaw G. Tedla, Bemnet A. Pickering, Darren Becker, Luke Wang, Lei Zhan, Bin Bottazzi, Maria Elena Loukas, Alex Sotillo, Javier Pearson, Mark S. |
author_sort | Mekonnen, Gebeyaw G. |
collection | PubMed |
description | Helminth parasites release extracellular vesicles which interact with the surrounding host tissues, mediating host–parasite communication and other fundamental processes of parasitism. As such, vesicle proteins present attractive targets for the development of novel intervention strategies to control these parasites and the diseases they cause. Herein, we describe the first proteomic analysis by LC-MS/MS of two types of extracellular vesicles (exosome-like, 120 k pellet vesicles and microvesicle-like, 15 k pellet vesicles) from adult Schistosoma haematobium worms. A total of 57 and 330 proteins were identified in the 120 k pellet vesicles and larger 15 k pellet vesicles, respectively, and some of the most abundant molecules included homologues of known helminth vaccine and diagnostic candidates such as Sm-TSP2, Sm23, glutathione S-transferase, saponins and aminopeptidases. Tetraspanins were highly represented in the analysis and found in both vesicle types. Vaccination of mice with recombinant versions of three of these tetraspanins induced protection in a heterologous challenge (S. mansoni) model of infection, resulting in significant reductions (averaged across two independent trials) in liver (47%, 38% and 41%) and intestinal (47%, 45% and 41%) egg burdens. These findings offer insight into the mechanisms by which anti-tetraspanin antibodies confer protection and highlight the potential that extracellular vesicle surface proteins offer as anti-helminth vaccines. |
format | Online Article Text |
id | pubmed-7563238 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-75632382020-10-27 Schistosoma haematobium Extracellular Vesicle Proteins Confer Protection in a Heterologous Model of Schistosomiasis Mekonnen, Gebeyaw G. Tedla, Bemnet A. Pickering, Darren Becker, Luke Wang, Lei Zhan, Bin Bottazzi, Maria Elena Loukas, Alex Sotillo, Javier Pearson, Mark S. Vaccines (Basel) Article Helminth parasites release extracellular vesicles which interact with the surrounding host tissues, mediating host–parasite communication and other fundamental processes of parasitism. As such, vesicle proteins present attractive targets for the development of novel intervention strategies to control these parasites and the diseases they cause. Herein, we describe the first proteomic analysis by LC-MS/MS of two types of extracellular vesicles (exosome-like, 120 k pellet vesicles and microvesicle-like, 15 k pellet vesicles) from adult Schistosoma haematobium worms. A total of 57 and 330 proteins were identified in the 120 k pellet vesicles and larger 15 k pellet vesicles, respectively, and some of the most abundant molecules included homologues of known helminth vaccine and diagnostic candidates such as Sm-TSP2, Sm23, glutathione S-transferase, saponins and aminopeptidases. Tetraspanins were highly represented in the analysis and found in both vesicle types. Vaccination of mice with recombinant versions of three of these tetraspanins induced protection in a heterologous challenge (S. mansoni) model of infection, resulting in significant reductions (averaged across two independent trials) in liver (47%, 38% and 41%) and intestinal (47%, 45% and 41%) egg burdens. These findings offer insight into the mechanisms by which anti-tetraspanin antibodies confer protection and highlight the potential that extracellular vesicle surface proteins offer as anti-helminth vaccines. MDPI 2020-07-24 /pmc/articles/PMC7563238/ /pubmed/32722279 http://dx.doi.org/10.3390/vaccines8030416 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Mekonnen, Gebeyaw G. Tedla, Bemnet A. Pickering, Darren Becker, Luke Wang, Lei Zhan, Bin Bottazzi, Maria Elena Loukas, Alex Sotillo, Javier Pearson, Mark S. Schistosoma haematobium Extracellular Vesicle Proteins Confer Protection in a Heterologous Model of Schistosomiasis |
title | Schistosoma haematobium Extracellular Vesicle Proteins Confer Protection in a Heterologous Model of Schistosomiasis |
title_full | Schistosoma haematobium Extracellular Vesicle Proteins Confer Protection in a Heterologous Model of Schistosomiasis |
title_fullStr | Schistosoma haematobium Extracellular Vesicle Proteins Confer Protection in a Heterologous Model of Schistosomiasis |
title_full_unstemmed | Schistosoma haematobium Extracellular Vesicle Proteins Confer Protection in a Heterologous Model of Schistosomiasis |
title_short | Schistosoma haematobium Extracellular Vesicle Proteins Confer Protection in a Heterologous Model of Schistosomiasis |
title_sort | schistosoma haematobium extracellular vesicle proteins confer protection in a heterologous model of schistosomiasis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563238/ https://www.ncbi.nlm.nih.gov/pubmed/32722279 http://dx.doi.org/10.3390/vaccines8030416 |
work_keys_str_mv | AT mekonnengebeyawg schistosomahaematobiumextracellularvesicleproteinsconferprotectioninaheterologousmodelofschistosomiasis AT tedlabemneta schistosomahaematobiumextracellularvesicleproteinsconferprotectioninaheterologousmodelofschistosomiasis AT pickeringdarren schistosomahaematobiumextracellularvesicleproteinsconferprotectioninaheterologousmodelofschistosomiasis AT beckerluke schistosomahaematobiumextracellularvesicleproteinsconferprotectioninaheterologousmodelofschistosomiasis AT wanglei schistosomahaematobiumextracellularvesicleproteinsconferprotectioninaheterologousmodelofschistosomiasis AT zhanbin schistosomahaematobiumextracellularvesicleproteinsconferprotectioninaheterologousmodelofschistosomiasis AT bottazzimariaelena schistosomahaematobiumextracellularvesicleproteinsconferprotectioninaheterologousmodelofschistosomiasis AT loukasalex schistosomahaematobiumextracellularvesicleproteinsconferprotectioninaheterologousmodelofschistosomiasis AT sotillojavier schistosomahaematobiumextracellularvesicleproteinsconferprotectioninaheterologousmodelofschistosomiasis AT pearsonmarks schistosomahaematobiumextracellularvesicleproteinsconferprotectioninaheterologousmodelofschistosomiasis |